Literature DB >> 7019356

Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections.

J F John, W F McNeill.   

Abstract

Strains of gentamicin-resistant Serratia marcescens (GRSM) that originated in a crowded neurosurgical close observation unit (COU) became established during a 2.5-year interval at several affiliated hospitals in Charleston, South Carolina. Most patients with GRSM had colonization or infection of the urinary tract associated with indwelling bladder catheters. Infected patients in the COU more often had pyuria and less often received systemic steroids than COU patients not harboring GRSM. However, length of stay, use of urinary catheters, exposure to systemic antibiotics, and exposure to gentamicin were not significantly different between the two groups. Of the strains of GRSM, 92% contained a conjugative 41-megadalton plasmid tht encoded resistance to ampicillin, carbenicillin, tetracycline, kanamycin, gentamicin, and tobramycin and elaborated similar aminoglycoside 3-acetyltransferases. Seven 41-megadalton plasmids from outbreak strains and a 41-megadalton plasmid from a 1973 isolate of GRSM gave identical DNA fragments after restriction endonuclease digestion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019356     DOI: 10.1093/infdis/143.6.810

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Development of a DNA probe from the deoxyribonucleotide sequence of a 3-N-aminoglycoside acetyltransferase [AAC(3)-I] resistance gene.

Authors:  F C Tenover; K L Phillips; T Gilbert; P Lockhart; P J O'Hara; J J Plorde
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

2.  Construction of a gentamicin resistance gene probe for epidemiological studies.

Authors:  D J Groot Obbink; L J Ritchie; F H Cameron; J S Mattick; V P Ackerman
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

3.  Hospital distribution, persistence, and reintroduction of related gentamicin R plasmids.

Authors:  S C Lee; D N Gerding; P P Cleary
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

4.  Frequency of aminoglycoside 6'-N-acetyltransferase among Serratia species during increased use of amikacin in the hospital.

Authors:  T A Larson; C R Garrett; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

Review 5.  Use of plasmid profiles in epidemiologic surveillance of disease outbreaks and in tracing the transmission of antibiotic resistance.

Authors:  L W Mayer
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

6.  Antibiotic resistance in Serratia marcescens.

Authors:  J D Sleigh
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

7.  Plasmid macroevolution in a nosocomial environment: demonstration of a persistent molecular polymorphism and construction of a cladistic phylogeny on the basis of restriction data.

Authors:  S C Lee; D N Gerding; P P Cleary
Journal:  Mol Gen Genet       Date:  1984

8.  Spheroplast induction in clinical isolates of Serratia marcescens in the presence of Ca2+ or Mg2+.

Authors:  Y Tada; J Yamaguchi
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

9.  Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens.

Authors:  J F John; W F McNeill; K E Price; P A Kresel
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

10.  Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit.

Authors:  Baek-Nam Kim; Soon-Im Choi; Nam-Hee Ryoo
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.